Back to Results
First PageMeta Content
Health / Influenza vaccine / FluMist / Influenza / Fluzone / H5N1 clinical trials / Flu pandemic vaccine / Vaccines / Vaccination / Medicine


Sanofi Pasteur Announces Publication of Positive Data for Fluzone® High-Dose Vaccine in The New England Journal of Medicine - Study Demonstrates Fluzone High-Dose Vaccine 24.2 Percent More Effective Than StandardDose Fl
Add to Reading List

Document Date: 2015-03-12 09:18:14


Open Document

File Size: 187,79 KB

Share Result on Facebook

City

New York / Paris / Nashville / LYON / /

Company

The New England Journal / Genzyme / Sanofi Pasteur US / Sanofi / Sanofi Pasteur / /

Country

France / United States / Canada / /

Currency

EUR / /

/

Event

Company Listing Change / FDA Phase / /

Facility

Vanderbilt University Medical Center / /

IndustryTerm

injection site / healthcare / therapeutic solutions / consumer healthcare / prevention of influenza disease / healthcare costs / diabetes solutions / /

MedicalCondition

headache / flu / strain / anaphylaxis / laboratory-confirmed influenza / Cardiac disorders / infectious agent / hypersensitivity / influenza A/H3N2 / influenza virus / illness / inactivated influenza / seasonal influenza disease / infections / Influenza / chronic conditions / pneumonia / influenza disease / seasonal influenza / Guillain-Barré syndrome / influenza A / diabetes / cardiovascular disease / erythema / fever / pain / only influenza / Infectious Diseases / standard-dose influenza / state-specific influenza / /

MedicalTreatment

active immunization / vaccination / /

Organization

Centers for Disease Control and Prevention / U.S. Census Bureau / U.S. Food and Drug Administration / Vanderbilt University Medical Center / /

Person

John Shiver / David P. Greenberg / Keipp Talbot / Sébastien Martel / Alain Bernal / Michael Szumera / /

/

Position

Senior Vice President / Research and Development / coordinating investigator / leader / Professor of Infectious Diseases / Vice President / Scientific & Medical Affairs / and Chief Medical Officer / integrated global healthcare leader / /

Product

Dose vaccine / /

ProvinceOrState

Tennessee / /

PublishedMedium

The New England Journal of Medicine / /

Region

New England / /

Technology

antibodies / therapeutic solutions / /

URL

http /

SocialTag